This work is licensed under the Creative Commons Attribution 4.0 International License.
Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors – current status: basic principles, operating procedures, shared indications, and emerging applications. Sem Oncol 2019; 46: 173–91. doi: 10.1053/j.seminoncol.2019.04.002CampanaLGMiklavčičDBertinoGMarconatoRValpioneSImarisioIElectrochemotherapy of superficial tumors – current status: basic principles, operating procedures, shared indications, and emerging applications2019461739110.1053/j.seminoncol.2019.04.002Open DOISearch in Google Scholar
Campana LG, Edhemović I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019; 45: 92–102. doi: 10.1016/j.ejso.2018.11.023CampanaLGEdhemovićISodenDPerroneAMScarpaMCampanacciLElectrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration2019459210210.1016/j.ejso.2018.11.023Open DOISearch in Google Scholar
Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9: 1–12. doi: 10.1186/1475-925X-9-10MiklavcicDSnojMZupanicAKosBCemazarMKropivnikMTowards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy2010911210.1186/1475-925X-9-10Open DOISearch in Google Scholar
Cindrič H, Miklavčič D, Cornelis FH, Kos B. Optimization of transpedicular electrode insertion for electroporation-based treatments of vertebral tumors. Cancers 2022; 14: 5412. doi: 10.3390/cancers14215412CindričHMiklavčičDCornelisFHKosBOptimization of transpedicular electrode insertion for electroporation-based treatments of vertebral tumors202214541210.3390/cancers14215412Open DOISearch in Google Scholar
Edhemovic I, Brecelj E, Gasljevic G, Marolt Music M, Gorjup V, Mali B, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014; 110: 320–7. doi: 10.1002/jso.23625EdhemovicIBreceljEGasljevicGMarolt MusicMGorjupVMaliBIntraoperative electrochemotherapy of colorectal liver metastases2014110320710.1002/jso.23625Open DOISearch in Google Scholar
Bianchi G, Campanacci L, Ronchetti M, Donati D. Electrochemotherapy in the treatment of bone metastases: a phase II trial. World J Surg 2016; 40: 3088–94. doi: 10.1007/s00268-016-3627-6BianchiGCampanacciLRonchettiMDonatiDElectrochemotherapy in the treatment of bone metastases: a phase II trial20164030889410.1007/s00268-016-3627-6Open DOISearch in Google Scholar
Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, et al. Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg 2015; 18: 230–6. doi: 10.1016/j.ijsu.2015.04.055.GranataVFuscoRPiccirilloMPalaiaRPetrilloALastoriaSElectrochemotherapy in locally advanced pancreatic cancer: preliminary results201518230610.1016/j.ijsu.2015.04.055Open DOISearch in Google Scholar
Simioni A, Valpione S, Granziera E, Rossi CR, Cavallin F, Spina R, et al. Ablation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 study. Sci Rep 2020; 10: 2291. doi: 10.1038/s41598-020-59230-wSimioniAValpioneSGranzieraERossiCRCavallinFSpinaRAblation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 study202010229110.1038/s41598-020-59230-wOpen DOISearch in Google Scholar
Tarantino L, Busto G, Nasto A, Nasto RA, Tarantino P, Fristachi R, et al. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study. Eur J Surg Oncol 2018; 44: 1603–9. doi: 10.1016/j.ejso.2018.06.025TarantinoLBustoGNastoANastoRATarantinoPFristachiRElectrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study2018441603910.1016/j.ejso.2018.06.025Open DOISearch in Google Scholar
Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874–82. doi: 10.1080/0284186X.2018.1454602GehlJSersaGMatthiessenLWMuirTSodenDOcchiniAUpdated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases2018578748210.1080/0284186X.2018.1454602Open DOISearch in Google Scholar
Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14–25. doi: 10.1016/j.ejcsup.2006.08.003MirLMGehlJSersaGCollinsCGGarbayJRBillardVStandard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes20064142510.1016/j.ejcsup.2006.08.003Open DOISearch in Google Scholar
Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol EJSO 2008; 34: 232–40. doi: 10.1016/j.ejso.2007.05.016SersaGMiklavcicDCemazarMRudolfZPuciharGSnojMElectrochemotherapy in treatment of tumours2008342324010.1016/j.ejso.2007.05.016Open DOISearch in Google Scholar
Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 1995; 55: 3450–5. PMID: 7614485SersaGCemazarMMiklavcicDAntitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice199555345057614485Search in Google Scholar
Orlowski S, Belehradek Jr J, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727–33. doi: 10.1016/0006-2952(88)90344-9OrlowskiSBelehradekJJrPaolettiCMirLMTransient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs19883747273310.1016/0006-2952(88)90344-9Open DOISearch in Google Scholar
Mir LM. Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 2006; 4: 38–44. doi: 10.1016/j.ejcsup.2006.08.005MirLMBases and rationale of the electrochemotherapy20064384410.1016/j.ejcsup.2006.08.005Open DOISearch in Google Scholar
Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729–46. doi: 10.1586/era.10.43JarmTCemazarMMiklavcicDSersaGAntivascular effects of electrochemotherapy: implications in treatment of bleeding metastases2010107294610.1586/era.10.43Open DOISearch in Google Scholar
Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388–98. doi: 10.1038/sj.bjc.6604168SersaGJarmTKotnikTCoerAPodkrajsekMSentjurcMVascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma2008983889810.1038/sj.bjc.6604168Open DOISearch in Google Scholar
Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PloS One 2013; 8: e59557. doi: 10.1371/journal.pone.0059557MarkelcBSersaGCemazarMDifferential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels20138e5955710.1371/journal.pone.0059557Open DOISearch in Google Scholar
Serša G, Miklavčič D, Čemažar M, Belehradek Jr J, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice. Bioelectrochem Bioenerg 1997; 43: 279–83. doi: 10.1016/S0302-4598(96)05194-XSeršaGMiklavčičDČemažarMBelehradekJJrJarmTMirLMElectrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice1997432798310.1016/S0302-4598(96)05194-XOpen DOISearch in Google Scholar
Calvet CY, Mir LM. The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev 2016; 35: 165–77. doi: 10.1007/s10555-016-9615-3CalvetCYMirLMThe promising alliance of anti-cancer electrochemotherapy with immunotherapy2016351657710.1007/s10555-016-9615-3Open DOISearch in Google Scholar
Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 2014; 13: 1–20. doi: 10.1186/1475-925X-13-29MiklavčičDMaliBKosBHellerRSeršaGElectrochemotherapy: from the drawing board into medical practice20141312010.1186/1475-925X-13-29Open DOISearch in Google Scholar
Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3–13. doi: 10.1016/j.ejcsup.2006.08.002MartyMSersaGGarbayJRGehlJCollinsCGSnojMElectrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study2006431310.1016/j.ejcsup.2006.08.002Open DOISearch in Google Scholar
Sano MB, Fan RE, Cheng K, Saenz Y, Sonn GA, Hwang GL, et al. Reduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model. J Vasc Interv Radiol 2018; 29: 893–8.e4. doi: 10.1016/j.jvir.2017.12.019SanoMBFanREChengKSaenzYSonnGAHwangGLReduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model2018298938.e410.1016/j.jvir.2017.12.019Open DOISearch in Google Scholar
Fusco R, Di Bernardo E, D’Alessio V, Salati S, Cadossi M. Reduction of muscle contraction and pain in electroporation-based treatments: an overview. World J Clin Oncol 2021; 12: 367. doi: 10.5306/wjco.v12.i5.367FuscoRDi BernardoED’AlessioVSalatiSCadossiMReduction of muscle contraction and pain in electroporation-based treatments: an overview20211236710.5306/wjco.v12.i5.367Open DOISearch in Google Scholar
Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur J Cancer Suppl 2006; 4: 45–51. doi: 10.1016/j.ejcsup.2006.08.006MiklavcicDCorovicSPuciharGPavseljNImportance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy20064455110.1016/j.ejcsup.2006.08.006Open DOISearch in Google Scholar
Martin RC, Schwartz E, Adams J, Farah I, Derhake BM. Intra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors. Anesthesiol Pain Med 2015; 5: e22786. doi: 10.5812/aapm.22786MartinRCSchwartzEAdamsJFarahIDerhakeBMIntra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors20155e2278610.5812/aapm.22786Open DOISearch in Google Scholar
Deodhar A, Dickfeld T, Single GW, Hamilton Jr WC, Thornton RH, Sofocleous CT, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. Am J Roentgenol 2011; 196: W330–5. doi: 10.2214/AJR.10.4490DeodharADickfeldTSingleGWHamiltonWCJrThorntonRHSofocleousCTIrreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization2011196W330510.2214/AJR.10.4490Open DOISearch in Google Scholar
Mali B, Jarm T, Corovic S, Paulin-Kosir MS, Cemazar M, Sersa G, et al. The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46: 745–57. doi: 10.1007/s11517-008-0346-7MaliBJarmTCorovicSPaulin-KosirMSCemazarMSersaGThe effect of electroporation pulses on functioning of the heart2008467455710.1007/s11517-008-0346-7Open DOISearch in Google Scholar
Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 2010; 110: 1305–9. doi: 10.1213/ane.0b013e3181d27b30BallCThomsonKRKavnoudiasHIrreversible electroporation: a new challenge in “out of operating theater” anesthesia20101101305910.1213/ane.0b013e3181d27b30Open DOISearch in Google Scholar
Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013; 107: 544–9. doi: 10.1002/jso.23280CannonREllisSHayesDNarayananGMartinRCSafety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures2013107544910.1002/jso.23280Open DOISearch in Google Scholar
Spallek H, Bischoff P, Zhou W, de Terlizzi F, Jakob F, Kovàcs A. Percutaneous electrochemotherapy in primary and secondary liver malignancies–local tumor control and impact on overall survival. Radiol Oncol 2022; 56: 102–10. doi: 10.2478/raon-2022-0003SpallekHBischoffPZhouWde TerlizziFJakobFKovàcsAPercutaneous electrochemotherapy in primary and secondary liver malignancies–local tumor control and impact on overall survival2022561021010.2478/raon-2022-0003Open DOISearch in Google Scholar
Cvetkoska A, Maček-Lebar A, Trdina P, Miklavčič D, Reberšek M. Muscle contractions and pain sensation accompanying high-frequency electroporation pulses. Sci Rep 2022; 12: 1–15. doi: 10.1038/s41598-022-12112-9CvetkoskaAMaček-LebarATrdinaPMiklavčičDReberšekMMuscle contractions and pain sensation accompanying high-frequency electroporation pulses20221211510.1038/s41598-022-12112-9Open DOISearch in Google Scholar
Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander MN, et al. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online 2011; 10: 1–21. doi: 10.1186/1475-925X-10-102ArenaCBSanoMBRossmeislJHCaldwellJLGarciaPARylanderMNHigh-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction20111012110.1186/1475-925X-10-102Open DOISearch in Google Scholar
Dong S, Wang H, Zhao Y, Sun Y, Yao C. First human trial of high-frequency irreversible electroporation therapy for prostate cancer. Technol Cancer Res Treat 2018; 17: 1533033818789692. doi: 10.1177/1533033818789692DongSWangHZhaoYSunYYaoCFirst human trial of high-frequency irreversible electroporation therapy for prostate cancer201817153303381878969210.1177/1533033818789692Open DOISearch in Google Scholar
van Es R, Konings MK, Du Pré BC, Neven K, van Wessel H, van Driel VJ, et al. High-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform. Biomed Eng OnLine 2019; 18: 1–13. doi: 10.1186/s12938-019-0693-7van EsRKoningsMKDu PréBCNevenKvan WesselHvan DrielVJHigh-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform20191811310.1186/s12938-019-0693-7Open DOISearch in Google Scholar
Ye X, Liu S, Yin H, He Q, Xue Z, Lu C, et al. Study on optimal parameter and target for pulsed-field ablation of atrial fibrillation. Front Cardiovasc Med 2021; 8: 690092. doi: 10.3389/fcvm.2021.690092YeXLiuSYinHHeQXueZLuCStudy on optimal parameter and target for pulsed-field ablation of atrial fibrillation2021869009210.3389/fcvm.2021.690092Open DOISearch in Google Scholar
Hartl S, Reinsch N, Füting A, Neven K. Pearls and pitfalls of pulsed field ablation. Korean Circ J 2022; 53: 273–93. doi: 10.4070/kcj.2023.0023HartlSReinschNFütingANevenKPearls and pitfalls of pulsed field ablation2022532739310.4070/kcj.2023.0023Open DOISearch in Google Scholar
Scuderi M, Rebersek M, Miklavcic D, Dermol-Cerne J. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro. Radiol Oncol 2019; 53: 194–205. doi: 10.2478/raon-2019-0025ScuderiMRebersekMMiklavcicDDermol-CerneJThe use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro20195319420510.2478/raon-2019-0025Open DOISearch in Google Scholar
Sweeney DC, Reberšek M, Dermol J, Rems L, Miklavčič D, Davalos RV. Quantification of cell membrane permeability induced by monopolar and high-frequency bipolar bursts of electrical pulses. Biochim Biophys Acta BBA-Biomembr 2016; 1858: 2689–98. doi: 10.1016/j.bbamem.2016.06.024SweeneyDCReberšekMDermolJRemsLMiklavčičDDavalosRVQuantification of cell membrane permeability induced by monopolar and high-frequency bipolar bursts of electrical pulses2016185826899810.1016/j.bbamem.2016.06.024Open DOISearch in Google Scholar
Lyons P, Polini D, Russell-Ryan K, Clover AJP. High-frequency electroporation and chemotherapy for the treatment of cutaneous malignancies: evaluation of early clinical response. Cancers 2023; 15: 3212. doi: 10.3390/cancers15123212LyonsPPoliniDRussell-RyanKCloverAJPHigh-frequency electroporation and chemotherapy for the treatment of cutaneous malignancies: evaluation of early clinical response202315321210.3390/cancers15123212Open DOISearch in Google Scholar
Pfefferle V, Häfner HM, Saur A, Kofler K, Kofler L. Electrochemotherapy in analgosedation for patients with reduced ability to receive general anesthesia. JDDG J Dtsch Dermatol Ges 2022; 20: 1384–6. doi: 10.1111/ddg.14855.PfefferleVHäfnerHMSaurAKoflerKKoflerLElectrochemotherapy in analgosedation for patients with reduced ability to receive general anesthesia2022201384610.1111/ddg.14855Open DOISearch in Google Scholar
Pfefferle V, Leiter U, Grünke T, Kofler K, Häfner HM, Kofler L. Electrochemotherapy under analgosedation – case report of a patient with Kaposi’s sarcoma. J Eur Acad Dermatol Venereol 2023; 37: e209–11. doi: 10.1111/jdv.18518PfefferleVLeiterUGrünkeTKoflerKHäfnerHMKoflerLElectrochemotherapy under analgosedation – case report of a patient with Kaposi’s sarcoma202337e2091110.1111/jdv.18518Open DOISearch in Google Scholar
Mir LM, Orlowski S, Belehradek Jr J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer Clin Oncol 1991; 27: 68–72. doi: 10.1016/0277-5379(91)90064-kMirLMOrlowskiSBelehradekJJrPaolettiCElectrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses199127687210.1016/0277-5379(91)90064-kOpen DOISearch in Google Scholar
Trotovšek B, Djokić M, Čemažar M, Serša G. New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies. World J Gastroenterol 2021; 27: 8216. doi: 10.3748/wjg.v27.i48.8216TrotovšekBDjokićMČemažarMSeršaGNew era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies202127821610.3748/wjg.v27.i48.8216Open DOISearch in Google Scholar
Heller R, Gilbert R, Jaroszeski MJ. Electrochemotherapy of murine melanoma using intratumor drug administration. Methods Mol Med 2000; 37: 253–7. doi: 10.1385/1-59259-080-2:253.HellerRGilbertRJaroszeskiMJElectrochemotherapy of murine melanoma using intratumor drug administration200037253710.1385/1-59259-080-2:253Open DOISearch in Google Scholar
Sedlar A, Jesenko T, Markelc B, Prosen L. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 2012; 46: 302–11. doi: 10.2478/v10019-012-0044-9SedlarAJesenkoTMarkelcBProsenLPotentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity2012463021110.2478/v10019-012-0044-9Open DOISearch in Google Scholar
Ursic K, Kos S, Kamensek U, Cemažar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Controlled Release 2021; 332: 623–35. doi: 10.1016/j.jconrel.2021.03.009UrsicKKosSKamensekUCemažarMMiceskaSMarkelcBPotentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status20213326233510.1016/j.jconrel.2021.03.009Open DOISearch in Google Scholar
Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315–27. doi: 10.1007/s00262-015-1724-2SersaGTeissieJCemazarMSignoriEKamensekUMarshallGElectrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer20156413152710.1007/s00262-015-1724-2Open DOISearch in Google Scholar
Rosazza C, Haberl Meglic S, Zumbusch A, Rols MP, Miklavcic D. Gene electrotransfer: a mechanistic perspective. Curr Gene Ther 2016; 16: 98–129. doi: 10.2174/1566523216666160331130040RosazzaCHaberl MeglicSZumbuschARolsMPMiklavcicDGene electrotransfer: a mechanistic perspective2016169812910.2174/1566523216666160331130040Open DOISearch in Google Scholar
Radzevičiūtė E, Malyško-Ptašinskė V, Kulbacka J, Rembia\lkowska N, Novickij J, Girkontaitė I, et al. Nanosecond electrochemotherapy using bleomycin or doxorubicin: influence of pulse amplitude, duration and burst frequency. Bioelectrochemistry 2022; 148: 108251. doi: 10.1016/j.bioelechem.2022.108251RadzevičiūtėEMalyško-PtašinskėVKulbackaJRembia\lkowskaNNovickijJGirkontaitėINanosecond electrochemotherapy using bleomycin or doxorubicin: influence of pulse amplitude, duration and burst frequency202214810825110.1016/j.bioelechem.2022.108251Open DOISearch in Google Scholar
Novickij V, Balevičiūtė A, Malyško V, Želvys A, Radzevičiūtė E, Kos B, et al. Effects of time delay between unipolar pulses in high frequency nano-electrochemotherapy. IEEE Trans Biomed Eng 2021; 69: 1726–32. doi: 10.1109/TBME.2021.3129176NovickijVBalevičiūtėAMalyškoVŽelvysARadzevičiūtėEKosBEffects of time delay between unipolar pulses in high frequency nano-electrochemotherapy20216917263210.1109/TBME.2021.3129176Open DOISearch in Google Scholar
Vizintin A, Markovic S, Scancar J, Kladnik J, Turel I, Miklavcic D. Nanosecond electric pulses are equally effective in electrochemotherapy with cisplatin as microsecond pulses. Radiol Oncol 2022; 56: 326–35. doi: 10.2478/raon-2022-0028VizintinAMarkovicSScancarJKladnikJTurelIMiklavcicDNanosecond electric pulses are equally effective in electrochemotherapy with cisplatin as microsecond pulses2022563263510.2478/raon-2022-0028Open DOISearch in Google Scholar
Cemazar M, Sersa G, Frey W, Miklavcic D, Teissié J. Recommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples. Bioelectrochemistry 2018; 122: 69–76. doi: 10.1016/j.bioelechem.2018.03.005CemazarMSersaGFreyWMiklavcicDTeissiéJRecommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples2018122697610.1016/j.bioelechem.2018.03.005Open DOISearch in Google Scholar
Protocol AG. CellTiter 96® AQueous One Solution Cell Proliferation Assay. Promega USA. [Internet]. [cited 2023 Oct 15]. Available at: https://www.promega.com/-/media/files/resources/protocols/technical-bulletins/0/celltiter-96-aqueous-one-solution-cell-proliferation-assay-system-protocol.pdfProtocolAGPromegaUSA[Internet]. [cited 2023 Oct 15]. Available at: https://www.promega.com/-/media/files/resources/protocols/technical-bulletins/0/celltiter-96-aqueous-one-solution-cell-proliferation-assay-system-protocol.pdfSearch in Google Scholar
Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1: 2315–19. doi: 10.1038/nprot.2006.339FrankenNARodermondHMStapJHavemanJVan BreeCClonogenic assay of cells in vitro2006123151910.1038/nprot.2006.339Open DOISearch in Google Scholar
Sweeney DC, Douglas TA, Davalos RV. Characterization of cell membrane permeability in vitro part II: computational model of electroporation-mediated membrane transport. Technol Cancer Res Treat 2018; 17: 1533033818792490. doi: 10.1177/1533033818792490SweeneyDCDouglasTADavalosRVCharacterization of cell membrane permeability in vitro part II: computational model of electroporation-mediated membrane transport201817153303381879249010.1177/1533033818792490Open DOISearch in Google Scholar
Mahnič-Kalamiza S, Miklavčič D, Vorobiev E. Dual-porosity model of solute diffusion in biological tissue modified by electroporation. Biochim Biophys Acta BBA-Biomembr 2014; 1838: 1950–66. doi: 10.1016/j.bbamem.2014.03.004Mahnič-KalamizaSMiklavčičDVorobievEDual-porosity model of solute diffusion in biological tissue modified by electroporation2014183819506610.1016/j.bbamem.2014.03.004Open DOISearch in Google Scholar
Nejad MA, Urbassek HM. Diffusion of cisplatin molecules in silica nano-pores: molecular dynamics study of a targeted drug delivery system. J Mol Graph Model 2019; 86: 228–34. doi: 10.1016/j.jmgm.2018.10.021NejadMAUrbassekHMDiffusion of cisplatin molecules in silica nano-pores: molecular dynamics study of a targeted drug delivery system2019862283410.1016/j.jmgm.2018.10.021Open DOISearch in Google Scholar
Panczyk T, Jagusiak A, Pastorin G, Ang WH, Narkiewicz-Michalek J. Molecular dynamics study of cisplatin release from carbon nanotubes capped by magnetic nanoparticles. J Phys Chem C 2013; 117: 17327–36. doi: 10.1021/jp405593uPanczykTJagusiakAPastorinGAngWHNarkiewicz-MichalekJMolecular dynamics study of cisplatin release from carbon nanotubes capped by magnetic nanoparticles2013117173273610.1021/jp405593uOpen DOISearch in Google Scholar
Jakštys B, Ruzgys P, Tamošiūnas M, Šatkauskas S. Different cell viability assays reveal inconsistent results after bleomycin electrotransfer in vitro. J Membr Biol 2015; 248: 857–63. doi: 10.1007/s00232-015-9813-xJakštysBRuzgysPTamošiūnasMŠatkauskasSDifferent cell viability assays reveal inconsistent results after bleomycin electrotransfer in vitro20152488576310.1007/s00232-015-9813-xOpen DOISearch in Google Scholar
Hucke A, Ciarimboli G. The role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations. J Clin Pharmacol 2016; 56: S157–72. doi: 10.1002/jcph.706HuckeACiarimboliGThe role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations201656S1577210.1002/jcph.706Open DOISearch in Google Scholar
Makovec T. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol 2019; 53: 148–58. doi: 10.2478/raon-2019-0018MakovecTCisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy2019531485810.2478/raon-2019-0018Open DOISearch in Google Scholar
Howell SB, Safaei R, Larson CA, Sailor MJ. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol 2010; 77: 887–94. doi: 10.1124/mol.109.063172HowellSBSafaeiRLarsonCASailorMJCopper transporters and the cellular pharmacology of the platinum-containing cancer drugs2010778879410.1124/mol.109.063172Open DOISearch in Google Scholar
Spreckelmeyer S, Orvig C, Casini A. Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin. Molecules 2014; 19: 15584–610. doi: 10.3390/molecules191015584SpreckelmeyerSOrvigCCasiniACellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin2014191558461010.3390/molecules191015584Open DOISearch in Google Scholar
Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 2012; 64: 706–21. doi: 10.1124/pr.111.005637ShenDWPouliotLMHallMDGottesmanMMCisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes2012647062110.1124/pr.111.005637Open DOISearch in Google Scholar
Pucihar G, Krmelj J, Reberšek M, Napotnik TB, Miklavčič D. Equivalent pulse parameters for electroporation. IEEE Trans Biomed Eng 2011; 58: 3279–88. doi: 10.1109/TBME.2011.2167232PuciharGKrmeljJReberšekMNapotnikTBMiklavčičDEquivalent pulse parameters for electroporation20115832798810.1109/TBME.2011.2167232Open DOISearch in Google Scholar
Peng W, Polajžer T, Yao C, Miklavčič D. Dynamics of cell death due to electroporation using different pulse parameters as revealed by different viability assays. Ann Biomed Eng 2023. [Internet]. doi: 10.1007/s10439-023-03309-8. Available at: https://www.researchgate.net/publication/373911137_Dynamics_of_Cell_Death_Due_to_Electroporation_Using_Different_Pulse_Parameters_as_Revealed_by_Different_Viability_AssaysPengWPolajžerTYaoCMiklavčičDDynamics of cell death due to electroporation using different pulse parameters as revealed by different viability assays2023[Internet].10.1007/s10439-023-03309-8Available at: https://www.researchgate.net/publication/373911137_Dynamics_of_Cell_Death_Due_to_Electroporation_Using_Different_Pulse_Parameters_as_Revealed_by_Different_Viability_AssaysOpen DOISearch in Google Scholar
Dermol-Černe J, Vidmar J, Ščančar J, Uršič K, Serša G, Miklavčič D. Connecting the in vitro and in vivo experiments in electrochemotherapy-a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model. J Controlled Release 2018; 286: 33–45. doi: 10.1016/j.jconrel.2018.07.021Dermol-ČerneJVidmarJŠčančarJUršičKSeršaGMiklavčičDConnecting the in vitro and in vivo experiments in electrochemotherapy-a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model2018286334510.1016/j.jconrel.2018.07.021Open DOISearch in Google Scholar
Daley-Yates PT, McBrien DC. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. Biochem Pharmacol 1984; 33: 3063–70. doi: 10.1016/0006-2952(84)90610-5Daley-YatesPTMcBrienDCCisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin19843330637010.1016/0006-2952(84)90610-5Open DOISearch in Google Scholar
Gately DP, Howell SB. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993; 67: 1171–6. doi: 10.1038/bjc.1993.221GatelyDPHowellSBCellular accumulation of the anticancer agent cisplatin: a review1993671171610.1038/bjc.1993.221Open DOISearch in Google Scholar
Rols MP, Femenia P, Teissie J. Long-lived macropinocytosis takes place in electropermeabilized mammalian cells. Biochem Biophys Res Commun 1995; 208: 26–35. doi: 10.1006/bbrc.1995.1300RolsMPFemeniaPTeissieJLong-lived macropinocytosis takes place in electropermeabilized mammalian cells1995208263510.1006/bbrc.1995.1300Open DOISearch in Google Scholar
Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30–40. doi: 10.1016/j.ejca.2020.06.020CloverAJPde TerlizziFBertinoGCuratoloPOdiliJCampanaLGElectrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)2020138304010.1016/j.ejca.2020.06.020Open DOISearch in Google Scholar
Cornelis FH, Ben Ammar M, Nouri-Neuville M, Matton L, Benderra MA, Gligorov J, et al. Percutaneous image-guided electrochemotherapy of spine metastases: initial experience. Cardiovasc Intervent Radiol 2019; 42: 1806–9. doi: 10.1007/s00270-019-02316-4CornelisFHBen AmmarMNouri-NeuvilleMMattonLBenderraMAGligorovJPercutaneous image-guided electrochemotherapy of spine metastases: initial experience2019421806910.1007/s00270-019-02316-4Open DOISearch in Google Scholar
Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, et al. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study. World J Gastroenterol 2017; 23: 906. doi: 10.3748/wjg.v23.i5.906TarantinoLBustoGNastoAFristachiRCacaceLTalamoMPercutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study20172390610.3748/wjg.v23.i5.906Open DOISearch in Google Scholar
Djokic M, Cemazar M, Stabuc M, Petric M, Smid LM, Jansa R, et al. Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement. Radiol Oncol 2020; 54: 347–52. doi: 10.2478/raon-2020-0038DjokicMCemazarMStabucMPetricMSmidLMJansaRPercutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement2020543475210.2478/raon-2020-0038Open DOISearch in Google Scholar
Gudvangen E, Kim V, Novickij V, Battista F, Pakhomov AG. Electroporation and cell killing by milli-to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation. Sci Rep 2022; 12: 1–15. doi: 10.1038/s41598-022-04868-xGudvangenEKimVNovickijVBattistaFPakhomovAGElectroporation and cell killing by milli-to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation20221211510.1038/s41598-022-04868-xOpen DOISearch in Google Scholar
Kim V, Gudvangen E, Kondratiev O, Redondo L, Xiao S, Pakhomov AG. Peculiarities of neurostimulation by intense nanosecond pulsed electric fields: how to avoid firing in peripheral nerve fibers. Int J Mol Sci 2021; 22: 7051. doi: 10.3390/ijms22137051KimVGudvangenEKondratievORedondoLXiaoSPakhomovAGPeculiarities of neurostimulation by intense nanosecond pulsed electric fields: how to avoid firing in peripheral nerve fibers202122705110.3390/ijms22137051Open DOISearch in Google Scholar
Jung J, Kim DH, Son J, Lee SK, Son BS. Comparative study between local anesthesia and general anesthesia in the treatment of primary spontaneous pneumothorax. Ann Transl Med 2019; 7: 553. doi: 10.21037/atm.2019.09.89JungJKimDHSonJLeeSKSonBSComparative study between local anesthesia and general anesthesia in the treatment of primary spontaneous pneumothorax2019755310.21037/atm.2019.09.89Open DOISearch in Google Scholar
Vižintin A, Marković S, Ščančar J, Miklavčič D. Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes. Bioelectrochemistry 2021; 140: 107798. doi: 10.1016/j.bioelechem.2021.107798VižintinAMarkovićSŠčančarJMiklavčičDElectroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes202114010779810.1016/j.bioelechem.2021.107798Open DOISearch in Google Scholar
Bendix MB, Houston A, Forde PF, Brint E. Electrochemotherapy and immune interactions; a boost to the system? Eur J Surg Oncol 2022; 48: 1895–900. doi: 10.1016/j.ejso.2022.05.023BendixMBHoustonAFordePFBrintEElectrochemotherapy and immune interactions; a boost to the system?202248189590010.1016/j.ejso.2022.05.023Open DOISearch in Google Scholar
Groselj A, Bosnjak M, Jesenko T, Cemazar M, Markelc B, Strojan P, et al. Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol. Radiol Oncol 2022; 56: 398–408. doi: 10.2478/raon-2022-0021GroseljABosnjakMJesenkoTCemazarMMarkelcBStrojanPTreatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol20225639840810.2478/raon-2022-0021Open DOISearch in Google Scholar
Napotnik TB, Polajžer T, Miklavčič D. Cell death due to electroporation–a review. Bioelectrochemistry 2021; 141: 107871. doi: 10.1016/j.bioelechem.2021.107871NapotnikTBPolajžerTMiklavčičDCell death due to electroporation–a review202114110787110.1016/j.bioelechem.2021.107871Open DOISearch in Google Scholar
Kesar U, Markelc B, Jesenko T, Ursic Valentinuzzi K, Cemazar M, Strojan P, et al. Effects of electrochemotherapy on immunologically important modifications in tumor cells. Vaccines 2023; 11: 925. doi: 10.3390/vaccines11050925KesarUMarkelcBJesenkoTUrsic ValentinuzziKCemazarMStrojanPEffects of electrochemotherapy on immunologically important modifications in tumor cells20231192510.3390/vaccines11050925Open DOISearch in Google Scholar
Calvet CY, Famin D, André FM, Mir LM. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. OncoImmunology 2014; 3: e28131. doi: 10.4161/onci.28131CalvetCYFaminDAndréFMMirLMElectrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells20143e2813110.4161/onci.28131Open DOISearch in Google Scholar
Gerlini G, Di Gennaro P, Borgognoni L. Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation. Oncoimmunology 2012; 1: 1655–7. doi: 10.4161/onci.21991GerliniGDi GennaroPBorgognoniLEnhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation201211655710.4161/onci.21991Open DOISearch in Google Scholar
Gerlini G, Sestini S, Di Gennaro P, Urso C, Pimpinelli N, Borgognoni L. Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 2013; 30: 37–45. doi: 10.1007/s10585-012-9505-1GerliniGSestiniSDi GennaroPUrsoCPimpinelliNBorgognoniLDendritic cells recruitment in melanoma metastasis treated by electrochemotherapy201330374510.1007/s10585-012-9505-1Open DOISearch in Google Scholar
Cemazar M, Ambrozic Avgustin J, Pavlin D, Sersa G, Poli A, Krhac Levacic A, et al. Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours. Vet Comp Oncol 2017; 15: 641–54. doi: 10.1111/vco.12208CemazarMAmbrozic AvgustinJPavlinDSersaGPoliAKrhac LevacicAEfficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours2017156415410.1111/vco.12208Open DOISearch in Google Scholar
Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, et al. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther 2010; 17: 457–64. doi: 10.1038/cgt.2010.6ReedSDFulmerABuckholzJZhangBCutreraJShiomitsuKBleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs2010174576410.1038/cgt.2010.6Open DOISearch in Google Scholar
Tratar UL, Milevoj N, Cemazar M, Znidar K, Valentinuzzi KU, Brozic A, et al. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12. Int Immunopharmacol 2023; 120: 110274. doi: 10.1016/j.intimp.2023.110274TratarULMilevojNCemazarMZnidarKValentinuzziKUBrozicATreatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12202312011027410.1016/j.intimp.2023.110274Open DOISearch in Google Scholar
Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896. doi: 10.1200/JCO.2007.15.6794DaudAIDeContiRCAndrewsSUrbasPRikerAISondakVKPhase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma200826589610.1200/JCO.2007.15.6794Open DOISearch in Google Scholar
Sachdev S, Potočnik T, Rems L, Miklavčič D. Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer. Bioelectrochemistry 2022; 144: 107994. doi: 10.1016/j.bioelechem.2021.107994SachdevSPotočnikTRemsLMiklavčičDRevisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer202214410799410.1016/j.bioelechem.2021.107994Open DOISearch in Google Scholar
Bulysheva A, Heller L, Francis M, Varghese F, Boye C, Heller R. Monopolar gene electrotransfer enhances plasmid DNA delivery to skin. Bioelectrochemistry 2021; 140: 107814. doi: 10.1016/j.bioelechem.2021.107814BulyshevaAHellerLFrancisMVargheseFBoyeCHellerRMonopolar gene electrotransfer enhances plasmid DNA delivery to skin202114010781410.1016/j.bioelechem.2021.107814Open DOISearch in Google Scholar
Smith TR, Patel A, Ramos S, Elwood D, Zhu X, Yan J, et al. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun 2020; 11: 2601. doi: 10.1038/s41467-020-16505-0SmithTRPatelARamosSElwoodDZhuXYanJImmunogenicity of a DNA vaccine candidate for COVID-19202011260110.1038/s41467-020-16505-0Open DOISearch in Google Scholar
Potočnik T, Maček Lebar A, Kos Š, Reberšek M, Pirc E, Serša G, et al. Effect of Experimental electrical and biological parameters on gene transfer by electroporation: a systematic review and meta-analysis. Pharmaceutics 2022; 14: 2700. doi: 10.3390/pharmaceutics14122700PotočnikTMaček LebarAKosŠReberšekMPircESeršaGEffect of Experimental electrical and biological parameters on gene transfer by electroporation: a systematic review and meta-analysis202214270010.3390/pharmaceutics14122700Open DOISearch in Google Scholar
Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, et al. High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy. Radiology 2020; 295: 254–72. doi: 10.1148/radiol.2020192190GeboersBSchefferHJGraybillPMRuarusAHNieuwenhuizenSPuijkRSHigh-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy20202952547210.1148/radiol.2020192190Open DOISearch in Google Scholar
Cindric H, Mariappan P, Beyer L, Wiggermann P, Moche M, Miklavcic D, et al. Retrospective study for validation and improvement of numerical treatment planning of irreversible electroporation ablation for treatment of liver tumors. IEEE Trans Biomed Eng 2021; 68: 3513–24. doi: 10.1109/TBME.2021.3075772CindricHMariappanPBeyerLWiggermannPMocheMMiklavcicDRetrospective study for validation and improvement of numerical treatment planning of irreversible electroporation ablation for treatment of liver tumors20216835132410.1109/TBME.2021.3075772Open DOISearch in Google Scholar
Scuderi M, Dermol-Černe J, da Silva CA, Muralidharan A, Boukany PE, Rems L. Models of electroporation and the associated transmembrane molecular transport should be revisited. Bioelectrochemistry 2022; 147: 108216. doi: 10.1016/j.bioelechem.2022.108216ScuderiMDermol-ČerneJda SilvaCAMuralidharanABoukanyPERemsLModels of electroporation and the associated transmembrane molecular transport should be revisited202214710821610.1016/j.bioelechem.2022.108216Open DOISearch in Google Scholar
Frandsen SK, Gehl J. A review on differences in effects on normal and malignant cells and tissues to electroporation-based therapies: a focus on calcium electroporation. Technol Cancer Res Treat 2018; 17: 1533033818788077. doi: 10.1177/1533033818788077FrandsenSKGehlJA review on differences in effects on normal and malignant cells and tissues to electroporation-based therapies: a focus on calcium electroporation201817153303381878807710.1177/1533033818788077Open DOISearch in Google Scholar
Polajžer T, Miklavčič D. Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics. Vaccines 2023; 11: 1036. doi: 10.3390/vaccines11061036PolajžerTMiklavčičDImmunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics202311103610.3390/vaccines11061036Open DOISearch in Google Scholar